WP 2.1 Animal model interventions: Polyunsaturated fatty acids (PUFA) and psychobiotics

Objective: To gain deeper insight into the underlying pathophysiology of the gut-brain interaction by substituting PUFA, psychobiotics or placebo in the activity based anorexia animal model and studying resulting changes in weight and hyperactivity.

Team:

PD Dr. med. Jochen Seitz
(PI) Department for Child and Adolescent Psychiatry (CAP),
RWTH University Hospital Aachen, Germany.
jseitzukaachende

Stefanie Trinh, PhD
Institute for Neuroanatomy,
RWTH University Hospital Aachen, Germany.
ntrinhukaachende

Anna Lotte Schotten, cand med.
Institute for Neuroanatomy,
RWTH University Hospital Aachen, Germany.
anna.schottenrwth-aachende

Olivia Peel, cand med.
Institute for Neuroanatomy,
RWTH University Hospital Aachen, Germany.
olivia.peelrwth-aachende

Lena Schaack, B. Sc.
Institute for Neuroanatomy,
RWTH University Hospital Aachen, Germany.
lena.schaackrwth-aachende

Cooperation:

Prof. Dr. hum. biol. Cordian Beyer
Director Institute for Neuroanatomy,
RWTH University Hospital Aachen, Germany.
cbeyerukaachende